Mellon Lisa, Brewer Linda, Hall Patricia, Horgan Frances, Williams David, Hickey Anne
Department of Psychology, Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, 2, Ireland.
Department of Geriatric and Stroke Medicine, Royal College of Surgeons in Ireland, Dublin, 2, Ireland.
BMC Neurol. 2015 Mar 12;15:31. doi: 10.1186/s12883-015-0288-2.
Cognitive impairment commonly occurs in the acute phase post-stroke, but may persist with over half of all stroke survivors experiencing some form of long-term cognitive deficit. Recent evidence suggests that optimising secondary prevention adherence is a critical factor in preventing recurrent stroke and the incidence of stroke-related cognitive impairment and dementia. The aim of this study was to profile cognitive impairment of stroke survivors at six months, and to identify factors associated with cognitive impairment post-stroke, focusing on indicators of adequate secondary prevention and psychological function.
Participants were assessed at six months following an ischaemic stroke as part of the Action on Secondary Prevention Interventions and Rehabilitation in Stroke study (ASPIRE-S), which examined the secondary preventive and rehabilitative profile of patients in the community post-stroke. Cognitive impairment was measured using the Montreal Cognitive Assessment (MoCA).
Two-hundred and fifty-six stroke patients were assessed at six months. Over half of the sample (56.6%) were found to have cognitive impairment, with significant associations between cognitive impairment and female sex (odds ratio (OR) = 1.6, 95% CI 1.01-2.57) and history of cerebrovascular disease (OR = 2.22, 95% CI 1.38-3.59). Treatment with antihypertensive medications (OR = .65, 95% CI .44-.96) and prescription of anticoagulant therapy (OR = .41, 95% CI .26-.68) were associated with reduced likelihood of cognitive impairment, however increasing number of total prescribed medications was moderately associated with poorer cognitive impairment (OR = 1.12, 95% CI 1.04-1.19).
Findings reveal levels of cognitive impairment at 6 months post-stroke that are concerning. Encouragingly, aspects of secondary prevention were identified that may be protective in reducing the incidence of cognitive impairment post-stroke. Neuropsychological rehabilitation post-stroke is also required as part of stroke rehabilitation models to meet the burden of post-stroke cognitive impairment.
认知障碍在中风急性期很常见,但可能持续存在,超过一半的中风幸存者会经历某种形式的长期认知缺陷。最近的证据表明,优化二级预防依从性是预防复发性中风以及中风相关认知障碍和痴呆症发病率的关键因素。本研究的目的是描述中风幸存者六个月时的认知障碍情况,并确定与中风后认知障碍相关的因素,重点关注充分二级预防和心理功能的指标。
作为中风二级预防干预与康复行动研究(ASPIRE-S)的一部分,参与者在缺血性中风六个月后接受评估,该研究考察了中风后社区患者的二级预防和康复情况。使用蒙特利尔认知评估量表(MoCA)测量认知障碍。
256名中风患者在六个月时接受了评估。超过一半的样本(56.6%)被发现有认知障碍,认知障碍与女性性别(优势比(OR)=1.6,95%置信区间1.01-2.57)和脑血管疾病史(OR=2.22,95%置信区间1.38-3.59)之间存在显著关联。使用抗高血压药物治疗(OR=0.65,95%置信区间0.44-0.96)和抗凝治疗处方(OR=0.41,95%置信区间0.26-0.68)与认知障碍可能性降低相关,然而,总处方药物数量增加与较差的认知障碍呈中度相关(OR=1.12,95%置信区间1.04-1.19)。
研究结果显示中风后六个月时的认知障碍水平令人担忧。令人鼓舞的是,确定了二级预防的一些方面可能对降低中风后认知障碍的发病率具有保护作用。中风后神经心理康复也是中风康复模式的一部分,以应对中风后认知障碍的负担。